Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study. (12th September 2022)

• Record Type: Journal Article
• Authors: Ayoubkhani, Daniel; Bosworth, Matthew L; King, Sasha; Pouwels, Koen B; Glickman, Myer; Nafilyan, Vahé; Zaccardi, Francesco; Khunti, Kamlesh; Alwan, Nisreen A; Walker, A Sarah
• Is Part Of: Open forum infectious diseases. Volume 9:Number 9(2022)
• Publication Date: 2022-09-12
• Subjects: coronavirus -- COVID-19 -- long COVID -- post-COVID condition -- vaccination; Communicable diseases -- Periodicals; Medical microbiology -- Periodicals; Infection -- Periodicals; 616.9
• DOI: 10.1093/ofid/ofac464
• Languages: English
• ISSNs: 2328-8957

Abstract

Abstract: We investigated long COVID incidence by vaccination status in a random sample of UK adults from April 2020 to November 2021. Persistent symptoms were reported by 9.5% of 3090 breakthrough severe acute respiratory syndrome coronavirus 2 infections and 14.6% of unvaccinated controls (adjusted odds ratio, 0.59 [95% confidence interval, .50–.69]), emphasizing the need for public health initiatives to increase population-level vaccine uptake.